Suppr超能文献

中国2型糖尿病患者肾小球滤过率预测新模型的开发与验证

Development and validation of new glomerular filtration rate predicting models for Chinese patients with type 2 diabetes.

作者信息

Chen Jinxia, Tang Hua, Huang Hui, Lv Linsheng, Wang Yanni, Liu Xun, Lou Tanqi

机构信息

Division of Nephrology, Department of Internal Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.

Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong, China.

出版信息

J Transl Med. 2015 Sep 28;13:317. doi: 10.1186/s12967-015-0674-y.

Abstract

BACKGROUND

Previous researches has depicted that the performance of the recommended glomerular filtration rate (GFR)-estimating equations in the type 2 diabetic population is inferior to that in the non-diabetic population. We attempted to develop new GFR-predicting models for use in Chinese patients with type 2 diabetes in this study.

METHODS

We enrolled 519 type 2 diabetic patients including a development data-set (n = 276), an internal validation data-set (n = 138) and an external validation data-set (n = 105) to establish new GFR-predicting models. 99mTc-DTPA-GFR revised by the dual sample method was referred to as the gold GFR standard.

RESULTS

Based on sex, age, serum creatinine and new predictor variables [body mass index (BMI), hemoglobinA1C, and urinary albumin creatinine ratio], eight new regression models and eight artificial neural network (ANN) models were developed. In the external validation group, only ANN3 was superior in both precision and accuracy over the original CKD-EPI equation (precision, 20.5 vs. 24.2 mL/min/1.73 m(2), P < 0.001; 30 % accuracy, 88.6 vs. 80.6 %, P = 0.02).

CONCLUSIONS

ANN3 based on sex, age, serum creatinine and BMI is the optimal model for GFR estimation in Chinese patients with type 2 diabetes.

摘要

背景

既往研究表明,推荐的肾小球滤过率(GFR)估算方程在2型糖尿病患者中的表现不如非糖尿病患者。在本研究中,我们试图开发适用于中国2型糖尿病患者的新GFR预测模型。

方法

我们纳入了519例2型糖尿病患者,包括一个开发数据集(n = 276)、一个内部验证数据集(n = 138)和一个外部验证数据集(n = 105),以建立新的GFR预测模型。通过双样本法校正的99mTc-DTPA-GFR被视为GFR的金标准。

结果

基于性别、年龄、血清肌酐和新的预测变量[体重指数(BMI)、糖化血红蛋白和尿白蛋白肌酐比值],开发了8个新的回归模型和8个人工神经网络(ANN)模型。在外部验证组中,仅ANN3在精密度和准确性方面均优于原始的CKD-EPI方程(精密度,20.5对24.2 mL/min/1.73 m²,P < 0.001;30%准确性,88.6对80.6%,P = 0.02)。

结论

基于性别、年龄、血清肌酐和BMI的ANN3是中国2型糖尿病患者GFR估算的最佳模型。

相似文献

引用本文的文献

4
Identification of Metabolite Markers Associated with Kidney Function.鉴定与肾功能相关的代谢物标志物。
J Immunol Res. 2022 Jul 26;2022:6190333. doi: 10.1155/2022/6190333. eCollection 2022.
8
Artificial Intelligence Methodologies and Their Application to Diabetes.人工智能方法及其在糖尿病中的应用。
J Diabetes Sci Technol. 2018 Mar;12(2):303-310. doi: 10.1177/1932296817710475. Epub 2017 May 25.

本文引用的文献

3
GFR estimation: from physiology to public health.肾小球滤过率估计:从生理学到公共卫生。
Am J Kidney Dis. 2014 May;63(5):820-34. doi: 10.1053/j.ajkd.2013.12.006. Epub 2014 Jan 28.
7
Chronic kidney disease: global dimension and perspectives.慢性肾脏病:全球维度与展望。
Lancet. 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X. Epub 2013 May 31.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验